• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[低高密度脂蛋白胆固醇、高甘油三酯——众所周知但常被忽视]

[Low HDL-cholesterol, high triglycerides--well known but often ignored].

作者信息

Benz R, Suter P M

机构信息

Medizinische Poliklinik, Hypertonie- und Adipositassprechstunde, Universitätsspital Zürich.

出版信息

Praxis (Bern 1994). 2004 Nov 10;93(46):1911-6. doi: 10.1024/0369-8394.93.46.1911.

DOI:10.1024/0369-8394.93.46.1911
PMID:15580883
Abstract

A reduced HDL-Cholersterol and increased triglyzerides are an often seen laboratory abnormality. They are known risk factors for arteriosclerosis. However the small influence of a pharamcologic treatment on the two reduced the interest in them. We therefore want to show the relation of the triglyzerides with the HDL-Cholesterol and the nonpharmacologic treatment of these two factors. Some clinical examples are illustrating the topic.

摘要

高密度脂蛋白胆固醇降低和甘油三酯升高是常见的实验室异常情况。它们是已知的动脉粥样硬化风险因素。然而,药物治疗对这两者的影响较小,降低了人们对它们的关注。因此,我们想展示甘油三酯与高密度脂蛋白胆固醇之间的关系以及这两个因素的非药物治疗方法。一些临床实例将说明这一主题。

相似文献

1
[Low HDL-cholesterol, high triglycerides--well known but often ignored].[低高密度脂蛋白胆固醇、高甘油三酯——众所周知但常被忽视]
Praxis (Bern 1994). 2004 Nov 10;93(46):1911-6. doi: 10.1024/0369-8394.93.46.1911.
2
[Dyslipidemia management in patients with impaired glucose tolerance].
Nihon Rinsho. 2005 Feb;63 Suppl 2:538-42.
3
[Drug clinics. Drug of the month. Atorvastatin (Lipitor)].[药物诊所。本月药物。阿托伐他汀(立普妥)]
Rev Med Liege. 1998 Jun;53(6):374-7.
4
No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin.
Perit Dial Int. 1999 Jan-Feb;19(1):89-91.
5
Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation.阿托伐他汀在肾移植术后高脂血症治疗中的有益作用。
Wien Klin Wochenschr. 2000 Apr 21;112(8):358-61.
6
Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes.2型糖尿病患者降脂治疗期间低密度脂蛋白大小变化的预测因素
Metabolism. 2004 Nov;53(11):1516. doi: 10.1016/j.metabol.2004.07.005.
7
[Effect of atorvastatin (liptonorm) on indicators of the lipid spectrum of blood in patients with the metabolic syndrome].[阿托伐他汀(立普妥)对代谢综合征患者血脂谱指标的影响]
Adv Gerontol. 2010;23(2):281-4.
8
Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemia.贝特类药物与小剂量阿托伐他汀联合治疗混合性高脂血症患者。
Curr Med Res Opin. 2002;18(3):125-8. doi: 10.1185/030079902125000372.
9
Last fall I began taking daily doses of 1,500 mg of niacin, in addition to the 40 mg of Lipitor I've been taking for several years. Within six months, my LDL and triglycerides were down significantly and my HDL was higher. If my next bi-annual blood test shows the same types of results, should I discontinue the Lipitor and niacin?去年秋天,我开始每天服用1500毫克烟酸,此外还服用我已经服用了几年的40毫克立普妥。在六个月内,我的低密度脂蛋白和甘油三酯显著下降,高密度脂蛋白升高。如果我接下来每半年一次的血液检查显示同样的结果,我应该停用立普妥和烟酸吗?
Heart Advis. 2008 Sep;11(9):8.
10
Lipid modifying action of atorvastatin in comparison to combination of atorvastatin and nicotinic acid in patients with ischaemic heart disease.阿托伐他汀与阿托伐他汀和烟酸联合用药对缺血性心脏病患者的脂质调节作用比较
Indian Heart J. 2011 Sep-Oct;63(5):434-7.